Condition
    Moderate Evidence
    Effectiveness 2/5

    Vitamin D for Chronic Pain

    Worth correcting if deficient; not an analgesic in people with adequate levels.

    Overview

    Worth correcting if deficient; not an analgesic in people with adequate levels.

    Verdict

    Mixed evidence

    Deficiency associates strongly with widespread pain, but supplementing people who are already replete does not reduce pain.

    How It Works

    Vitamin D receptors are expressed in muscle, nerve and immune tissue, and deficiency causes osteomalacia with characteristic bone and muscle pain. It also modulates inflammatory cytokine production and may influence nociceptive processing, though the mechanistic case for analgesia at replete levels is weak.

    Dosing & Protocol

    Typical dose

    Recommended dose
    1000-2000 IU daily maintenance, higher correction dosing guided by a 25-hydroxyvitamin D level
    Expected timeframe
    8-12 weeks after correcting a true deficiency

    Protocol

    form
    Vitamin D3 (cholecalciferol)
    duration
    3-6 months with a pain score at baseline and end
    co factor
    Take with the largest meal. Evidence is mixed: systematic reviews of vitamin D for chronic pain, including fibromyalgia and non-specific musculoskeletal pain, show small and inconsistent benefits overall, with the clearest improvement confined to people who were genuinely deficient at baseline. In replete people the trials are null.
    titration
    Target 75-125 nmol/L; do not exceed 4000 IU/day without supervision
    starting dose
    Test 25-hydroxyvitamin D. If deficient, replete under medical guidance; otherwise 1000-2000 IU (25-50 mcg) daily with a fat-containing meal

    Evidence

    What the studies say

    Observational studies repeatedly link low 25-hydroxyvitamin D with chronic widespread pain, fibromyalgia and higher opioid use, but confounding is severe since pain limits outdoor activity and mobility. Randomised trials tell a more sober story. Meta-analyses of supplementation in chronic pain populations show small or null effects overall, with the clearest benefit confined to trials enrolling genuinely deficient participants. In a randomised trial in fibromyalgia patients with low vitamin D, correction reduced pain scores; in replete populations, the VITAL trial and others found no analgesic effect. The practical rule is diagnostic rather than therapeutic: measure, correct a real deficiency, and if severe deficiency was the cause, expect meaningful improvement in bone and muscle pain within months. If levels were adequate, look elsewhere.

    Effect of vitamin D supplementation on pain: a systematic review and meta-analysis

    Score: 7/10
    2016
    meta_analysis
    n=8815

    Wu Z, Malihi Z, Stewart AW

    Vitamin D produced a small reduction in mean pain score, mainly in deficient participants.

    View source

    Safety

    Caveats

    High intermittent bolus dosing has been associated with increased falls and fractures in older adults. Excessive long-term intake risks hypercalcaemia. Caution in sarcoidosis and other granulomatous disease.

    Less likely to help if

    People with normal vitamin D levels — supplementation adds nothing to pain outcomes.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.